• Go to navigation
  • Go to content
Nexium

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com

Main navigation

  • Home
  • Prescribing Information
  • Mode of Action
  • Contact Us

You are here

  • Home
  • Mode of Action

Nexium® (esomeprazole) is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of H+/K+-ATPase in the gastric parietal cell. By acting specifically on the proton pump, Nexium blocks the final step in acid production, thus reducing gastric acidity. This effect is dose-related up to a daily dose of 20–40 mg and leads to inhibition of gastric acid secretion.

 

Review period : 12 months
Last reviewed : June 20

Page tools

  • Print
  • Bookmark this page

Information

This website has been produced in accordance with both the ABPI Code of Practice for the Pharmaceutical Industry 2008 and the EFPIA Code on the Promotion of Prescription-only Medicines to, and interactions with, Healthcare Professionals

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010